FDA

Scholar argues that FDA should reform its regulation of algorithm-based medicine.

Scholar argues that financial regulators must be decisive yet agile when using imperfect information.

Scholar praises a California law that widely eliminates antibiotics use in the livestock industry.

Scholar weighs the possibility of regulating medical artificial intelligence like human professionals.

Legislatures reconsider whether students can access sunscreen in school without a doctor’s note.

Scholar argues that recent FDA regulations may keep smokers in the dark about e-cigarettes.

FDA should encourage states to be the primary regulators of stem cell procedures.

Expert argues that federal law gives regulator authority to restrict unauthorized drug uses.

Lawyer argues that United States should ramp up regulation of dietary supplements.

Legal scholar argues for greater reliance on entrepreneurial strategies in regulation.

Scholar argues U.S.-China trade agreements fill regulatory gaps left by both countries.

Legal scholar reexamines the formal rulemaking process in response to criticism.